FI955382A0 - Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi - Google Patents

Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi

Info

Publication number
FI955382A0
FI955382A0 FI955382A FI955382A FI955382A0 FI 955382 A0 FI955382 A0 FI 955382A0 FI 955382 A FI955382 A FI 955382A FI 955382 A FI955382 A FI 955382A FI 955382 A0 FI955382 A0 FI 955382A0
Authority
FI
Finland
Prior art keywords
preparation
acid addition
addition salts
new crystalline
cephemic
Prior art date
Application number
FI955382A
Other languages
English (en)
Swedish (sv)
Other versions
FI955382A (fi
FI120263B (fi
Inventor
Rudolf Lattrell
Walter Duerckheimer
Peter Schmid
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI955382A0 publication Critical patent/FI955382A0/fi
Publication of FI955382A publication Critical patent/FI955382A/fi
Application granted granted Critical
Publication of FI120263B publication Critical patent/FI120263B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI955382A 1994-11-10 1995-11-08 Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi FI120263B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4440141 1994-11-10
DE4440141A DE4440141A1 (de) 1994-11-10 1994-11-10 Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung

Publications (3)

Publication Number Publication Date
FI955382A0 true FI955382A0 (fi) 1995-11-08
FI955382A FI955382A (fi) 1996-05-11
FI120263B FI120263B (fi) 2009-08-31

Family

ID=6532953

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955382A FI120263B (fi) 1994-11-10 1995-11-08 Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi

Country Status (28)

Country Link
US (1) US5747484A (fi)
EP (1) EP0711774B1 (fi)
JP (1) JP3920939B2 (fi)
KR (1) KR100449191B1 (fi)
CN (1) CN1066452C (fi)
AR (1) AR002246A1 (fi)
AT (1) ATE213248T1 (fi)
AU (1) AU707730B2 (fi)
BR (1) BR9505132A (fi)
CA (1) CA2162530C (fi)
CZ (1) CZ290936B6 (fi)
DE (2) DE4440141A1 (fi)
DK (1) DK0711774T3 (fi)
ES (1) ES2172549T3 (fi)
FI (1) FI120263B (fi)
HU (1) HU219475B (fi)
IL (1) IL115914A (fi)
MA (1) MA23709A1 (fi)
NO (1) NO311891B1 (fi)
NZ (1) NZ280424A (fi)
OA (1) OA10242A (fi)
PL (1) PL182806B1 (fi)
PT (1) PT711774E (fi)
RU (1) RU2161619C2 (fi)
SK (1) SK282545B6 (fi)
TR (1) TR199501392A2 (fi)
TW (1) TW422847B (fi)
ZA (1) ZA959510B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2288199A1 (en) * 1997-04-29 1998-11-05 The University Of New Mexico Hydroxynaphthoic acids and derivatives
MXPA05004219A (es) * 2002-10-25 2005-06-08 Akzo Nobel Nv Composicion farmaceutica de liberacion prolongada.
EP1945223B1 (en) * 2005-10-29 2010-07-07 Intervet International BV Cefquinome compositions and methods of their use
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
EP3616695A1 (en) 2011-09-09 2020-03-04 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections
EP2750706A4 (en) * 2011-09-29 2015-04-15 Alere San Diego Inc 2-HYDROXYHIPPURIC ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS AND USE
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA2162530A1 (en) 1996-05-11
DE59510048D1 (de) 2002-03-21
AU3772895A (en) 1996-05-16
US5747484A (en) 1998-05-05
MA23709A1 (fr) 1996-07-01
IL115914A (en) 2002-08-14
CZ293395A3 (en) 1996-05-15
RU2161619C2 (ru) 2001-01-10
HU219475B (hu) 2001-04-28
CA2162530C (en) 2007-07-31
ATE213248T1 (de) 2002-02-15
DK0711774T3 (da) 2002-04-22
KR100449191B1 (ko) 2006-01-12
FI955382A (fi) 1996-05-11
TR199501392A2 (tr) 1996-07-21
NZ280424A (en) 1997-06-24
OA10242A (fr) 1997-09-19
EP0711774A1 (de) 1996-05-15
ZA959510B (en) 1996-05-28
NO311891B1 (no) 2002-02-11
DE4440141A1 (de) 1996-05-15
PL182806B1 (pl) 2002-03-29
IL115914A0 (en) 1996-01-31
ES2172549T3 (es) 2002-10-01
AU707730B2 (en) 1999-07-15
SK282545B6 (sk) 2002-10-08
AR002246A1 (es) 1998-03-11
JP3920939B2 (ja) 2007-05-30
FI120263B (fi) 2009-08-31
CN1129220A (zh) 1996-08-21
PT711774E (pt) 2002-07-31
CN1066452C (zh) 2001-05-30
TW422847B (en) 2001-02-21
HUT74163A (en) 1996-11-28
KR960017670A (ko) 1996-06-17
HU9503213D0 (en) 1996-01-29
NO954511L (no) 1996-05-13
SK139795A3 (en) 1996-06-05
JPH08208662A (ja) 1996-08-13
CZ290936B6 (cs) 2002-11-13
EP0711774B1 (de) 2002-02-13
BR9505132A (pt) 1997-09-09
NO954511D0 (no) 1995-11-09
PL311326A1 (en) 1996-05-13

Similar Documents

Publication Publication Date Title
FI963298A0 (fi) Hydrokseemihappo- ja karboksyylihappojohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö
FI861505A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten indolijohdannaisten ja niiden happoadditiosuolojen valmistamiseksi
FI940874A (fi) Menetelmä maitohapon ja maitohappoestereiden valmistamiseksi
FI972313A (fi) Uusia 2,3-diketopiperatsiinijohdannaisia ja niiden suoloja
FI95704B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI955382A0 (fi) Uudet kiteiset kefemihappoadditiosuolat ja menetelmä niiden valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI963050A (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
FI972065A (fi) Menetelmä N-fosfonometyyliglysiinin valmistamiseksi
FI891144A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
FI93119B (fi) Uusien tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI972265A0 (fi) Menetelmä cefotaksimin valmistamiseksi ja uusia natriumsuoloja
FI900145A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI942581A0 (fi) Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi
FI962880A0 (fi) Menetelmä ja välituotteita naftyridonikarboksyylihapposuolojen valmistusta varten
FR2555578B1 (fr) Procede de preparation de derives d'azetidinone
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
IT9022209A0 (it) Processo per la granulazione di sali potessici
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
FR2632303B1 (fr) Procede de preparation du 3-aminocrotonate de methyle
FR2591221B1 (fr) Procede de preparation d'a-aminoacides
FI951441A (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
NO994261D0 (no) FremgangsmÕte for fremstilling av trovafloxacinsyresalter
IT1170269B (it) Procedimento per preparare l'acido dl 2-(6'-metossi-2'-naftil)-propionico
IT9019485A1 (it) Acidi 2-(2, 4-diaril-ossazol-5-il)-alcancarbossilici, loro esteri e sali metodi per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH

Free format text: SANOFI-AVENTIS DEUTSCHLAND GMBH

FG Patent granted

Ref document number: 120263

Country of ref document: FI

MA Patent expired